After a meal, gut incretin hormones are secreted and promote postprandial insulin secretion and regulate glucagon secretion, and the interest in selective glucagon-like peptide-1 (GLP-1) receptor agonists for the treatment of T2D and obesity has increased(162). The gene discussed is INS; the disease is obesity disorder.